Complement components sC5b-9 and CH50 predict prognosis in heart failure patients combined with hypertension.
Heart failure (HF), resulting from inflammation and vessel injury, is one of the leading causes of poor quality of life and premature death. The complement system plays a leading role in vessel integrity and inflammation response. However, the association between serum complement level and the prognosis of HF remains unclear. In our study, a total of 263 newly diagnosed hypertension patients with HF were included. Eight classical Cardiovascular(CV) risk factors were collected, and plasma C3a, C3b, C5a, sC5b-9, and CH50 levels were detected. Compared with control group, plasma C5a(p<0.001), sC5b-9 (p<0.001) and CH50 (p=0.004) levels of hypertension patients with HF were significantly increased. Based on univariate analysis, an older age, higher frequency of alcohol consumption, high level of BMI, medium or high risk of hypertension, hyperlipidemia, and diabetes were poor prognostic factors while low levels of C5a, sC5b-9 and CH50 were associated with favorable overall survival (OS). When these factors fit into a multivariate regression model, patients with hyperlipidemia (P=0.002, HR=3.09), NT-pro-BNP ≥ 14.8 (P<0.001, HR=11.14), sC5b-9 level ≥ 1406.2 ug/ml (P=0.180, HR=5.51) or CH50 level ≥ 294.6 ug/ml (P<0.001, HR=4.57) remained statistically factors for worsened OS and regarded as independent risk factors. These independently associated risk factors were used to form an OS estimation nomogram. Nomogram demonstrated good accuracy in estimating the risk, with a bootstrap-corrected C index of 0.789. sC5b-9 and CH50 levels are increased in hypertension patients with HF. Nomogram based on multivariate analysis has good accuracy in estimating the risk of OS.